Qué está moviendo el mercado.

Kairos Pharma announces 1-for-7 reverse stock split to maintain NYSE compliance

* Kairos Pharma (KAPA [https://seekingalpha.com/symbol/KAPA]) announced on Friday that it will conduct a 1-for-7 reverse stock split effective September 1, 2026, before the market opens. * The company’s shares will continue trading on the…

Bayer (XTRA:BAYN) Stock Still Looks Reasonable On New Prostate Cancer News

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Bayer's share price has climbed sharply over the past year, yet the valuation checks still suggest the stock screens as cheap on se…

Bayer (XTRA:BAYN) Stock Gets Two New Research Deals In Cancer And Heart Health

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Bayer announced two new collaborations, one with Kairos Pharma on a prostate cancer therapy and another with Henry Ford Heal…

Kairos Pharma Announces Strategic Collaboration with Bayer to Enhance XOFIGO Activity in Metastatic Prostate Cancer

Combination Targets a $570M–$1.3B Addressable Global Market; ENV-105 Phase 2 Data Show 86% Clinical Benefit Rate in Resistant mCRPC LOS ANGELES, July 22, 2026--(BUSINESS WIRE)--Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage bi…

Kairos Pharma Reports Breakthrough Interim Safety Data in Phase 1 Trial of ENV-105 in EGFR-Mutated Lung Cancer Patients — Targeting a $10 Billion Drug Resistance Market

Zero Grade 3+ Toxicities associated with ENV-105 in 13 Patients; ENV-105 (Carotuximab) Demonstrates Clean Safety Profile in Combination with Osimertinib (AstraZeneca's Tagrisso®) — Advancing Kairos's Mission to Resensitize the Largest Unme…

Pre-Market Movers: PMI, CNTB, RNAZ Chart The Course

(RTTNews) - Pre-market trading is offering an early glimpse into biotech stocks likely to attract investor attention this Wednesday. Significant price moves ahead of the opening bell are being driven by clinical trial updates, public and p…

KAPA Investors Have Opportunity to Join Kairos Pharma, Ltd. Fraud Investigation with the Schall Law Firm

LOS ANGELES, April 28, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Kairos Pharma, Ltd. (“Kairos” or “the Company”) (NYSE A…

Kairos Pharma Signs Term Sheet To Acquire Two Oncology Assets From Celyn Therapeutics; Stock Up

(RTTNews) - Kairos Pharma Ltd. (KAPA), a clinical-stage biopharmaceutical company focused on cancer therapeutics, announced the signing of a term sheet to acquire two clinical oncology assets from privately held Celyn Therapeutics, Inc. Th…

5 Biotech Stocks To Watch Ahead Of Major Clinical Trial Data Readouts In September 2025

(RTTNews) - September 2025 could be a make-or-break month for some biotech stocks, as the companies prepare to release critical clinical trial data. The following are some of the biotech stocks to watch in September, with potential catalys…

Form 10Q Kairos Pharma Ltd For: 12 August

Top Midday Gainers

Longevity Health (XAGE) shares almost doubled amid heavy trading after the company said late Monday PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium ne…